Human Health Innovation

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation.

human scientist

Latest Articles on Human Health

Drug Discovery Human Health

With a pipeline of around 90 clinical and pre-clinical projects, and the potential to deliver up to 20 new therapy approvals over the next seven years, we continue our track record of long-term innovation-led performance.

The rise of drug-resistant pathogens is a real threat.
Human Health Innovation

“Rapid progress towards clinical candidates”

Michel Pairet, Member of the Board of Managing Directors, explains why Boehringer Ingelheim expands its commitment to fighting drug resistant infections with a new joint venture.

Related Press Releases